Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IVIEW-1201 for Acute Adenoviral Conjunctivitis
CTR20202563Phase 2Terminated
- Sponsor
- IVIEW Therapeutics Inc.
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of povidone-iodine in adenoviral conjunctivitis, sponsored by IVIEW Therapeutics Inc.. Started Dec 2020; status: terminated.
02
Drugs
povidone-iodine
03
Conditions
adenoviral conjunctivitis
Beyond the preview
Go deeper on CTR20202563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20202563.